[Treatment of Advanced Squamous Cell Lung Cancer]

Yixiang Zhu1, Puyuan Xing1, Junling Li1

  • 1National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.

Insights

Squamous cell lung cancer (SQCLC) treatment remains challenging, with limited options beyond chemotherapy for advanced stages. This review systematically explores current therapeutic strategies for SQCLC.

Area of Science:

  • Oncology
  • Pulmonology
  • Cancer Research

Background:

  • Lung cancer is a leading cause of cancer death globally.
  • Non-small cell lung cancer (NSCLC) comprises 85% of lung cancer diagnoses.
  • Squamous cell lung cancer (SQCLC), a subtype of NSCLC, accounts for 20-30% of cases.

Purpose of the Study:

  • To systematically review the current treatment landscape for squamous cell lung cancer.
  • To highlight the limitations of existing therapies, particularly for advanced stages.
  • To provide an overview of treatment options for SQCLC patients.

Main Methods:

  • Systematic review of literature on squamous cell lung cancer treatments.
  • Analysis of current therapeutic mainstays including surgery, chemotherapy, and targeted therapies.
  • Evaluation of the efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in SQCLC.

Main Results:

  • Advanced stage diagnosis often precludes surgical intervention for SQCLC.
  • EGFR-TKIs, successful in lung adenocarcinoma, show limited efficacy in advanced SQCLC.
  • Platinum-based chemotherapy remains the primary treatment for advanced SQCLC.

Conclusions:

  • There is a significant unmet need for effective treatments for advanced squamous cell lung cancer.
  • Current therapeutic strategies for SQCLC are limited, with chemotherapy being the standard.
  • Further research is crucial to develop novel and effective therapies for SQCLC.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K